{
    "root": "6fb899dd-d30f-4391-9c79-cf79d4aec06f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Fluocinonide",
    "value": "20250513",
    "ingredients": [
        {
            "name": "Fluocinonide",
            "code": "2W4A77YPAN"
        },
        {
            "name": "glyceryl monostearate",
            "code": "230OU9XXE4"
        },
        {
            "name": "propylene carbonate",
            "code": "8D08K3S51E"
        },
        {
            "name": "propylene glycol",
            "code": "6DC9Q167V3"
        },
        {
            "name": "petrolatum",
            "code": "4T6H12BN9U"
        },
        {
            "name": "white wax",
            "code": "7G1J5DA97F"
        }
    ],
    "indications": "Fluocinonide Cream USP, 0.05%, Fluocinonide Cream USP, 0.05% (Emulsified Base), Fluocinonide Gel USP, 0.05% and Fluocinonide Ointment USP, 0.05% are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.",
    "contraindications": "Fluocinonide Cream USP, 0.05%, Fluocinonide Cream USP, 0.05% (Emulsified Base), Fluocinonide Gel USP, 0.05% and Fluocinonide Ointment USP, 0.05% are generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition.\n                  Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.\n                  If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.",
    "warningsAndPrecautions": null,
    "adverseReactions": "Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations."
}